Innovation in total hip replacement--when is new better?

Area of Science:

• Orthopaedic Surgery
• Biomaterials Science
• Medical Device Innovation

Background:

• Continued introduction of novel total hip replacement (THR) designs necessitates robust evaluation methods.
• Existing THR designs demonstrate high success rates, but ongoing innovation aims for enhanced materials and sizing options.
• Assessing the efficacy of new THR implants for routine use presents a challenge due to the need for long-term follow-up data.

Discussion:

• Proposes utilizing the collective expertise of the orthopaedic community to establish design specifications for successful THR.
• Advocates for federal funding to develop and validate comprehensive test methods for new THR technologies.
• Emphasizes the 'Design Method,' a systematic approach involving preclinical and clinical testing across all use scenarios, for device validation.

Key Insights:

• New THR designs should be evaluated using established design specifications and validated testing protocols.
• A multi-faceted validation approach, including preclinical and clinical assessments, is crucial for new hip implant technologies.
• The orthopaedic community's knowledge should guide the formulation of standards for successful total hip replacement designs.

Outlook:

• Federal funding is recommended for the research community to develop extensively validated test methods for medical devices.
• The Design Method, encompassing a series of methodical tests, is essential for validating innovations in hip replacement.
• While no simple answers exist for design validation, recent trends suggest a more careful introduction of innovations, promising improved long-term results in hip arthroplasty.